The gene therapies for cardiomyopathies market is poised for strong growth as advancements in genomic medicine accelerate the ...

Immense progress in gene-editing, drug discovery and conservation are just some of the reasons to be cheerful about 2025.

Once limited to nonspecific anti-inflammatory therapies, expanding treatment options for atopic dermatitis are allowing therapy to be individualized.

A new study from the Max Planck Institute for Evolutionary Anthropology examined how > 2,000 clinically approved drugs affect ...

Qihan Biotech, a clinical-stage biotechnology company developing off-the-shelf cell therapies for autoimmune diseases and ...

Highlights included the news that global renewable energy generation has become the number one power source and that the ...

Engineered oncolytic bacteria have emerged as a promising therapeutic platform for precision cancer treatment, offering tumor ...

BostonGene has won four awards in the Research & Development, Product Launches, and Innovation categories in the 2025 ...

The Promobilia Foundation is donating SEK 25 million to enable four research groups from Karolinska Institutet and Lund ...

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK ...

As head team physician for the New York Giants, I routinely have athletes asking about supposed ‘breakthrough’ stem cell ...

Engineered oncolytic bacteria have emerged as a promising therapeutic platform for precision cancer treatment, offering tumor ...